E
MRNA icon

Ergoteles’s Moderna MRNA Stock Holding History

Ergoteles’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-801
Closed -$203K – 1487
2021
Q4 		$203K Sell
801
-11,735
-94% -$3.43M 0.01% 1025
2021
Q3 		$4.83M Sell
12,536
-30,313
-71% -$11.2M 0.18% 153
2021
Q2 		$10.1M Buy
+42,849
New +$7.66M 0.23% 131
2021
Q1 		– Sell
-47,108
Closed -$4.92M – 966
2020
Q4 		$4.92M Buy
+47,108
New +$4.77M 0.16% 142

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ergoteles's MRNA Position: Q1 2022 in Review

Ergoteles sold out of Moderna (MRNA) in Q1 2022, closing a stake of 801 shares — an estimated $203K sold.

Ergoteles first reported a position in MRNA in Q4 2020 and held it in 4 quarters. The position peaked at $10.1M in Q2 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Ergoteles reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Ergoteles sold 801 Moderna shares in Q1 2022, an estimated $203K.
  • Ergoteles first reported a position in Moderna in Q4 2020 and held it in 4 quarters.
  • Ergoteles's Moderna position peaked at $10.1M in Q2 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.